IGF1 and metastatic neoplasm: These data are consistent with our own and others’ observations, including the recent report of IGF1 amplification in 14% of osteosarcomas [1, 15, 16], although IGF1 plays less of a role for driving primary tumour to metastatic tumour gene expression (Fig. 1c).